Vivekanand Veluchamy
Neurology with Special Qualifications in Child Neurology · Canton, OHNPI 1750576898
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 190 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by UCB, Inc. at 29.6% of the total.
Across 190 payments — averaging $21.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$1K
- Neurelis, Inc.$446
- SK Life Science, Inc.$332
- Biocodex, Inc.$227
- Catalyst Pharmaceuticals, Inc.$188
- Greenwich Biosciences, Inc.$158
- plus $1K from 27 others
What the payments were for
- Travel & lodging$190%
- Food & beverage$3,94098%
- Education$632%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 58 | $1,190 |
| Neurelis, Inc. | 14 | $446 |
| SK Life Science, Inc. | 18 | $332 |
| Biocodex, Inc. | 9 | $227 |
| Catalyst Pharmaceuticals, Inc. | 13 | $188 |
| Greenwich Biosciences, Inc. | 2 | $158 |
| AstraZeneca(2 entities) | 9 | $157 |
| Jazz Pharmaceuticals Inc. | 7 | $144 |
| Mallinckrodt Enterprises LLC | 3 | $137 |
| Argenx US, Inc. | 7 | $118 |
| Genentech USA, Inc. | 4 | $103 |
| Teva Pharmaceuticals USA, Inc. | 6 | $97 |
| Acadia Pharmaceuticals Inc | 5 | $97 |
| AbbVie | 2 | $75 |
| CSL Behring | 3 | $55 |
| Neurocrine Biosciences, Inc. | 3 | $53 |
| EMD Serono, Inc. | 3 | $48 |
| Lundbeck LLC | 2 | $41 |
| Biogen | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Lilly USA, LLC | 2 | $31 |
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| Aucta Pharmaceuticals, Inc. | 3 | $29 |
| Eisai Inc. | 1 | $28 |
| Sarepta Therapeutics, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 2 | $22 |
| Livanova USA, Inc. | 1 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Merz Pharmaceuticals, LLC | 1 | $16 |
| Pfizer | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Acorda Therapeutics, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,021 in reported general payments places this provider in the 65th percentile of 113 neurology with special qualifications in child neurology providers in Ohio.
See all neurology with special qualifications in child neurology providers in Ohio →
Other neurology with special qualifications in child neurology in Canton
- Morris KinastCanton$2K
- Hope O'BrienCincinnati$525K
- Ajay GuptaCleveland$261K
- Anne ConnollyColumbus$154K
- Tracy GlauserCincinnati$130K
- Cuixia TianCincinnati$91K
- Aaron AbramsCleveland$88K
- Shannon StandridgeCincinnati$79K
- Emily DelosreyesColumbus$79K
- Samiah Al-ZaidyColumbus$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.